APA

Vergote I. B., Lund B., Peen U., Umajuridze Z., Mau-Sorensen M., Kranich A., Van Nieuwenhuysen E., Haslund C., Nottrup T., Han S. N., Concin N., Unger T. J., Chai Y., Au N., Rashal T., Joshi A., Crochiere M., Landesman Y., Shah J., Shacham S., Kauffman M. & Mirza M. R. (20200505). Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies. : Gynecologic oncology.

Chicago

Vergote I B, Lund B, Peen U, Umajuridze Z, Mau-Sorensen M, Kranich A, Van Nieuwenhuysen E, Haslund C, Nottrup T, Han S N, Concin N, Unger T J, Chai Y, Au N, Rashal T, Joshi A, Crochiere M, Landesman Y, Shah J, Shacham S, Kauffman M and Mirza M R. 20200505. Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies. : Gynecologic oncology.

Harvard

Vergote I. B., Lund B., Peen U., Umajuridze Z., Mau-Sorensen M., Kranich A., Van Nieuwenhuysen E., Haslund C., Nottrup T., Han S. N., Concin N., Unger T. J., Chai Y., Au N., Rashal T., Joshi A., Crochiere M., Landesman Y., Shah J., Shacham S., Kauffman M. and Mirza M. R. (20200505). Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies. : Gynecologic oncology.

MLA

Vergote I B, Lund B, Peen U, Umajuridze Z, Mau-Sorensen M, Kranich A, Van Nieuwenhuysen E, Haslund C, Nottrup T, Han S N, Concin N, Unger T J, Chai Y, Au N, Rashal T, Joshi A, Crochiere M, Landesman Y, Shah J, Shacham S, Kauffman M and Mirza M R. Phase 2 study of the Exportin 1 inhibitor selinexor in patients with recurrent gynecological malignancies. : Gynecologic oncology. 20200505.